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Foreword
This booklet is a revised edition o f the NIOSH docum ent Histoplasmosis: Protecting Workers at Risk, which 
was originally published in September 1997. The updated inform ation in  this booklet will help readers under­
stand what histoplasmosis is and recognize activities that may expose workers to the disease-causing fungus 
Histoplasma capsulatum . The booklet also informs readers about methods they can use to protect themselves 
and others from exposure.
Outbreaks o f histoplasmosis have shared similar circumstances: People who did not know the health risks of 
breathing in  the spores o f H . capsulatum  became ill and sometimes caused others nearby to become ill when 
they disturbed contam inated soil or accumulations o f bird or bat manure. Because they were unaware o f the 
hazard, they did not take protective measures that could have prevented illness.
This booklet will help prevent such exposures by serving as a guide for safety and health professionals, 
environmental consultants, supervisors, and others responsible for the safety and health o f those working near 
material contaminated with H. capsulatum. Activities that pose a health risk to workers at these sites include 
disturbance o f soil at an active or inactive bird roost or poultry house, excavation in  regions where this 
fungus is endemic, and removal o f bat or bird manure from buildings.
Local, State, and national public health professionals may also find this booklet useful for understanding the 
health risks o f exposure to H. capsulatum  so that they can provide guidance about work practices and 
personal protective equipment. The appendix consists o f a fact sheet about histoplasmosis printed in  English 
and Spanish. This fact sheet is intended to help educate workers and the general public about this disease. We 
urge employers, health agencies, unions, and cooperatives to distribute the fact sheet to all potentially 
exposed workers.
Occupational Safety and Health 
Centers for Disease Control and Prevention
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Histoplasmosis 
Protecting Workers at Risk
What is histoplasmosis?
Histoplasmosis is an infectious disease caused by 
inhaling the spores of a fungus called Histoplasma  
capsulatum. Histoplasmosis is not contagious; it 
cannot be transm itted from an infected person or 
animal to someone else.(1)
H. capsulatum  is a dimorphic fungus, which means 
it has two forms.(2,3) It is a mold (mycelial phase) in 
soil at am bient tem peratures, and after being 
inhaled by humans or animals, it produces a yeast 
phase when spores undergo genetic, biochemical, 
and physical alterations.®  Spores o f H. capsulatum  
are oval and have two sizes. M acroconidia (large 
spores) have diam eters ranging from  8 to 15 
micrometers (pm), and m icroconidia (small spores) 
range from 2 to 5 pm in diameter.(3) Yeast cells of 
H. capsulatum  have oval to round shapes and diam ­
eters ranging from 1 to 5 pm.(3-5)
Histoplasmosis prim arily affects a person’s lungs, 
and its symptoms vary greatly. The vast majority of 
infected people are asymptomatic (have no apparent 
ill effects), or they experience symptoms so mild 
they do not seek medical attention and may not even 
realize that their illness was histoplasm osis.(6) If 
symptoms do occur, they will usually start within 3 
to 17 days after exposure, with an average of 
10 days.(1) Histoplasmosis can appear as a mild, 
flu-like respiratory illness and has a combination of 
symptoms, including malaise (a general ill feeling), 
fever, chest pain, dry or nonproductive cough, 
headache, loss o f appetite, shortness o f breath, joint 
and muscle pains, chills, and hoarseness.(1,3,6-8)
A chest X-ray o f a person with acute pulmonary 
histoplamosis will commonly show a patchy pneu­
monitis, which eventually calcifies.(3)
Several years ago, pulmonary calcifications were 
thought to be associated with healed tuberculosis, 
when a person had actually had histoplasmosis 
instead. During the same period, individuals with 
histoplasmosis were admitted mistakenly to tuber­
culosis sanatoriums.(9) Unfortunately, some histo­
plasm osis patients acquired tuberculosis while 
residing in  open wards with tuberculosis patients.(3)
Chronic lung disease due to histoplasmosis resem ­
bles tuberculosis and can worsen over months or 
years. Special antifungal medications are needed to 
arrest the disease.(1,5,6,10-12) The m ost severe and 
rarest form o f this disease is disseminated histo­
plasmosis, which involves spreading o f the fungus 
to other organs outside the lungs. Disseminated 
histoplasmosis is fatal if  untreated,(1,13) but death 
can also occur in  some patients even when medical 
treatment is received.(12) People with weakened 
immune systems are at the greatest risk for devel­
oping severe and dissem inated histoplasm osis. 
Included in  this high-risk group are persons with 
acquired immunodeficiency syndrome (AIDS) or 
cancer and persons receiving cancer chemotherapy; 
high-dose, long-term  steroid therapy; or other 
im muno-suppressive drugs.(6,12,14-18)
A person who has had histoplasmosis can experi­
ence reinfection after reexposure to H. capsulatum. 
Persons with im munity to H. capsulatum  who 
becom e reinfected  will usually  experience a
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heightened inflam m atory response, but they will 
have a less severe illness o f shorter duration than 
what resulted from the primary infection.(3,5)
Not to be confused with reinfection, reactivation of 
latent (inactive) histoplasmosis can occur in  elderly 
and im munocomprom ised individuals years after 
infection by H. capsulatum S2,5 The metabolic 
activity of dorm ant yeasts and the methods that 
enable a microorganism to escape elim ination by a 
host’s immune system are unknown.*191
Im paired vision can develop in  som e people 
because o f a rare condition called “presumed ocular 
histoplasm osis syndrom e.”(3,5,20-22) The factors 
causing this condition are poorly understood, and 
there is no scientific basis establishing H. capsula­
tum  as its cause.(5) Results o f laboratory tests sug­
gest that presum ed ocular histoplasmosis is associ­
ated with hypersensitivity to H. capsulatum  and not 
from direct exposure o f the eyes to the m icroorgan­
ism. W hat delayed events convert the condition 
from  asym ptom atic to sym ptom atic are also 
unknown.*23 This syndrome should not be con­
fused with the involvement of the eye associated on 
rare occasions w ith dissem inated histoplasm o- 
sis.(3,5) Because the lesions o f presumed ocular 
histoplasmosis syndrome do not progress, treatment 
is not necessary; however, treatment is essential 
with active cases o f histoplasmosis o f the eye.(24)
How is histoplasmosis diagnosed?
Histoplasmosis can be diagnosed by identifying 
H. capsulatum  in  clinical samples of a symptomatic 
person’s tissues or secretions, testing the patient’s 
blood serum for antibodies to the microorganism, 
and testing urine, serum, or other body fluids for 
H. capsulatum  antigen.(3) On occasion, diagnosis 
may require a transbronchial biopsy.(14)
Culturing of H. capsulatum
Culturing clinical specimens is a standard method 
of m icrobial identification, but the culturing
process for isolating H. capsulatum  is costly and 
time-consum ing.(25) To complicate matters, positive 
results are seldom obtained during the acute stage 
o f the illness, except from clinical specimens from 
patients with disseminated histoplasmosis.(6,12,14,25-27) 
However, research advances in polymerase chain reac­
tion technology have resulted in methods that provide 
rapid, first-line detection and prospective identification 
of H  capsulatum in clinical samples.(24_30)
Serologic tests
Serologic evidence is often the prime factor in  the 
diagnosis o f histoplasm osis.(31) Rapid and accurate 
determ ination o f serologic test results depends on 
the proper collection, storage, and shipment of 
serum specimens. Thus, following guidelines estab­
lished for these activities is essential.(31-33)
Because o f their convenience, availability, and util­
ity, the m ost widely accepted serologic tests are the 
im munodiffusion test and the complement-fixation 
test.(8,25-27) Serologic test results are useful when 
positive. However, sometimes test results are nega­
tive even when a person is sick with histoplasmosis, 
a situation that arises especially in  patients with 
weakened immune system s.(6,14,26)
The immunodiffusion test qualitatively measures 
precipitating antibodies (H and M precipitin lines or 
bands) to concentrated histoplasmin.(8,14,34) While 
this test is more specific for histoplasmosis (i.e., a 
person who is not infected with H. capsulatum  is 
unlikely to have a positive test result) than the com- 
plement-fixation test, it is less sensitive (i.e., some­
one who is acutely infected can have a negative test 
result).(8,14,25) Because the H band o f the im m uno­
diffusion test is usually present for only 4  to 6  weeks 
after exposure, it indicates active infection.(6,8,25) 
The M band is observed more frequently, appears 
soon after infection, and may persist up to 3  years 
after a patient recovers.(8,14)
The complement-fixation test, which measures anti­
bodies to the intact yeast form and mycelial (histo- 
plasmin) antigen, is more sensitive but less specific
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than the immunodiffusion test.(14) Complement-fix­
ing antibodies may appear in 3 to 6 weeks (some­
times as early as 2 weeks(34)) following infection by 
H. capsulatum , and repeated tests will give positive 
results for months.(6,34) The results o f complement- 
fixation tests are o f greatest diagnostic usefulness 
when both acute and convalescent serum specimens 
can be obtained. A high titer (1:32 or higher) or a 
fourfold increase is indicative o f active histoplasmo- 
sis.(8,26,27,34) Lower titers (1:8 or 1:16), although less 
specific, may also provide presumptive evidence of 
infection,(7,25) but they can also be measured in the 
serum o f healthy persons from regions where histo­
plasmosis is endemic.(27) Antibody titers will gradu­
ally decline and eventually disappear months to
years after a patient recovers.(6,8,25,34)
Detection of H. capsulatum antigen
A radioimmunoassay m ethod can be used to m ea­
sure H. capsulatum  polysaccharide antigen (HPA) 
levels in  samples o f a patient’s urine, serum, and 
other body fluids.(12,25,35,36) The test appears to 
m eet the im portant need for a rapid and accurate 
m ethod for early diagnosis o f dissem inated histo­
plasmosis, especially in  patients with AID S.(12,25,36) 
HPA is detected in  body fluid samples o f most 
patients with disseminated infection and in  the 
urine and serum o f 25% to 50% of those with less 
severe infections.(25)
Histoplasmin skin test
The manufacturing o f diluted histoplasmin for skin 
testing was stopped in  January, 2000. The skin test­
ing reagents were still unavailable when these 
guidelines were updated in  2004. A person could 
learn from a histoplasmin skin test whether he or 
she had been previously infected by H. capsulatum. 
This test, similar to a tuberculin skin test, had been 
available at many physicians’ offices and medical 
clinics. A  histoplasmin skin test became positive 2 
to 4 weeks after a person was infected by H. capsu­
latum , and repeated tests usually gave positive 
results for the rest o f the person’s life.(26) W hile 
histoplasmin skin test inform ation was useful to 
epidemiologists, a positive skin test did not help
diagnose acute histoplasmosis, unless a previous 
skin test was known to have been negative.(6,8,14) A 
previous infection by H. capsulatum  can provide 
partial protection against ill effects i f  a person is 
reinfected.(34) Since a positive skin test does not 
mean that a person is completely protected against 
ill effects,(34) appropriate exposure precautions 
should be taken regardless o f a worker’s skin-test 
status in  the past.
Where are H. capsulatum 
spores found?
H. capsulatum  grows in  soils throughout the 
world.(2,14) In the United States, the fungus is 
endemic and the proportion o f people infected by 
H. capsulatum  is higher in  central and eastern 
states, especially along the Ohio and Mississippi 
River valleys.(3,8,37) The fungus seems to grow best 
in  soils having a high nitrogen content, especially 
those enriched with bird manure or bat droppings. 
The organism can be carried on the wings, feet, and 
beaks of birds and infect soil under roosting sites or 
manure accumulations inside or outside buildings. 
Active and inactive roosts o f blackbirds (e.g., star­
lings, grackles, red-winged blackbirds, and cow- 
birds) have been found heavily contaminated by 
H. capsulatum .(34,38,50) Therefore, the soil in  a stand 
o f trees w here blackbirds have roosted  
for 3 or more years should be suspected o f being 
contam inated by the fungus.(42,51) Habitats of 
pigeons(38-40,52-54) and bats,(38,55-72) and poultry 
houses with dirt floors(38,73-78) have also been 
found contaminated by H. capsulatum .
On the other hand, fresh b ird  droppings 
on surfaces such as sidewalks and windowsills have 
not been shown to present a health risk  for 
histoplasmosis because birds themselves do not 
appear to be infected by H. capsulatum .(34,79) 
Rather, b ird  m anure is prim arily  a nutrient 
source for the growth o f H. capsulatum  already 
present in soil.(27) Unlike birds, bats can become 
infected with H. capsulatum  and consequently 
can excrete the organism  in  their drop-
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Increasing numbers o f resident Canada geese in  
urban and suburban areas have caused concern 
about whether droppings and water contaminated 
by their droppings are possible sources of disease 
transm ission to humans. As with exposures to the 
fresh droppings of other birds, exposures to goose 
droppings have not been shown to be a health risk 
for histoplasmosis. However, the hum an pathogens 
C ryptosporidium , Giardia, and C am pylobacter 
have been found in  Canada goose droppings.(81-83) 
The fecal-oral route is the primary route of ingest­
ing pathogens that could cause infection and dis­
ease, notably diarrhea and gastroenteritis.(82) Thus, 
people working in areas frequented by Canada 
geese, such as ground maintenance workers at golf 
courses and parks, should take precautions to pre­
vent hand-to-mouth contact with droppings.(81)
To learn whether soil or droppings are contaminated 
with H. capsulatum spores, samples must be collected 
and cultured. The culturing process involves inoculat­
ing mice with small portions o f a sample, sacrific­
ing the mice after 4 weeks, and streaking agar plates 
with portions o f each m ouse’s liver and spleen.(38) 
Then for four more weeks, the plates are watched 
for the growth o f H. capsulatum. Enough samples 
m ust be collected so that small but highly contam i­
nated areas are not overlooked. On several occa­
sions, H. capsulatum  has not been recovered from 
any o f the samples collected from material believed 
responsible for causing illness in  people diagnosed 
from the results o f clinical tests as having histoplas- 
m osis.(39,40,61,74,84-86) M olecular techniques, such 
as polymerase chain reaction methods that produce 
results in  days instead o f weeks, may provide less 
costly and quicker methods o f analyzing soil sam ­
ples for H. capsulatum .(87)
Until a less expensive and more rapid method is 
available, testing field samples for H. capsulatum  
will be impractical in  most situations. Consequently, 
when thorough testing is not done, the safest 
approach is to assume that the soil in  regions where 
H. capsulatum  is endemic and any accumulations of 
bat droppings or bird manure are contaminated with
H. capsulatum  and to take appropriate exposure 
precautions.
Who can get histoplasmosis 
and what jobs and activities put 
people at risk for exposure to 
H. capsulatum spores?
Anyone working at a job or present near activities 
where material contam inated with H. capsulatum  
becomes airborne can develop histoplasmosis if  
enough spores are inhaled. After an exposure, how 
ill a person becomes varies greatly and most likely 
depends on the number o f spores inhaled and a per­
son’s age and susceptibility to the disease. The 
number o f inhaled spores needed to cause disease is 
unknown. Generally, very few people will develop 
symptomatic disease after a low-level exposure to 
material contam inated with H. capsulatum  spores. 
However, longer durations o f exposure and expo­
sure to higher concentrations o f airborne contam i­
nated material increase a person’s risk o f develop­
ing histoplasm osis.(5) Children younger than 2 
years o f age, persons with com prom ised immune 
systems, and older persons, in  particular those with 
underlying illnesses such as diabetes and chronic 
lung disease, are at increased risk for developing 
symptomatic histoplasm osis.(3,4,14,88)
The U.S. Public Health Service (USPHS) and the 
Infectious Diseases Society o f Am erica (IDSA) 
have jointly published guidelines for the prevention 
o f opportunistic infections in  persons infected with 
the hum an im munodeficiency virus (HIV).(89) The 
U SPH S/ID SA  Prevention o f Opportunistic 
Infections Working Group recom m ended that HIV- 
infected persons “should avoid activities known to 
be associated with increased risk (e.g., creating dust 
when working with surface soil; cleaning chicken 
coops that are heavily contam inated with drop­
pings; disturbing soil beneath bird-roosting sites; 
cleaning, remodeling, or demolishing old buildings; 
and exploring caves).”(89) HIV-infected persons 
should consult their health care provider about 
appropriate exposure precautions that should be
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taken for any activity with a risk of exposure to
H. capsulatum .
Below is a partial list of occupations and hobbies 
with risks for exposure to H. capsulatum  spores. 
Appropriate exposure precautions should be taken 
by these people and others whenever contaminated 
soil, bat droppings, or bird manure is disturbed.






> Heating and air-conditioning system installer or 
service person(8,61)
> Microbiology laboratory worker(23,53,64,86)
> Pest control worker
> Restorer o f historic or abandoned buildings(61,64)
> Roofer(52)
> Spelunker (cave explorer)(56,59,60,68-71)
If someone who engages in these activities develops 
flu-like symptoms days or even weeks after disturb­
ing m aterial that m ight be contam inated with 
H. capsulatum , and the illness worsens rather than 
subsides after a few days, medical care should be 
sought and the health care provider inform ed about 
the exposure.
O utbreaks of h is to p lasm o sis  have occu rred  
am ong people who w ere infected  by H. capsula­
tum  even though they had no part in  the activities 
that caused contam inated m aterial to becom e
aerosolized.(39,52,92,93)
After a small group of students raked and swept a 
20-year accumulation of dirt, leaves, and debris in  a 
middle school’s courtyard on Earth D ay-1970,
nearly 400 people (mostly students) developed 
histoplasmosis.(92) The school’s forced-air ventila­
tion system, which had fresh air intakes in the 
courtyard, was im plicated  as being prim arily  
responsible for spreading contam inated air through­
out the school. Results of the outbreak investigation 
showed that a few students developed histoplasm o­
sis despite being absent from school on the day 
when the courtyard was cleaned. This finding sug­
gests that exposures to spore-contaminated dust 
continued for a day or more after cleaning of the 
courtyard was stopped.
During a histoplasmosis outbreak in 2001, 523 peo­
ple (439 of them were students) met a laboratory- 
confirmed case definition of histoplasmosis follow­
ing the rototilling o f a 10-foot by 45-foot area o f soil 
within a high school’s courtyard.(93) Spore-contami­
nated air entered a wing of the school most likely 
through open windows that faced the courtyard and 
heating, ventilating, and air-conditioning systems 
that had fresh air intakes in  the courtyard. As with 
the 1970 Earth Day outbreak, this study’s findings 
also showed that a few persons were infected despite 
being absent from school on the day of the rototill- 
ing activity and the following day.
Should workers who might be 
exposed to H. capsulatum have 
pre-exposure skin or blood tests?
If a histoplasmin test was available again, workers 
at risk of exposure to H. capsulatum  m ight learn 
useful inform ation from skin testing. The results of 
skin testing would inform  each worker of his or her 
status regarding either susceptibility to infection by 
H. capsulatum  (a negative skin test) or partial pro­
tection against ill effects if reinfected (a positive 
skin test). However, a false-negative skin test result 
can be reported early in an infection or with persons
w ith w eakened im m une system s.(6,8,14,26,34) A
false-positive skin test can result from cross-reac­
tions with antigens of certain other pathogenic 
fungi.(8,37) One drawback to routine pre-exposure 
skin testing is that a person with a positive skin test
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m ight incorrectly assume a false sense of security 
that he or she is completely protected against ill 
effects if reinfected. The work practices and per­
sonal protective equipm ent described in  this book­
let are expected to protect both skin-test positive 
and skin-test negative persons from  excessive 
inhalation exposures to materials that m ight be con­
tam inated with H. capsulatum .
Although a pre-exposure serum sample could be 
useful in  determ ining w hether a w orker’s 
post-exposure illness is histoplasmosis, routine col­
lection and storage of serum  specim ens from 
workers is unnecessary and impractical in most 
work settings. Some employers, such as public 
health agencies and microbiology laboratories, have 
facilities for long-term  storage of serum and do col­
lect pre-exposure serum specimens from those 
employees who m ight be exposed to high-risk 
infectious agents. If a worker is to have blood 
drawn for this purpose and is to receive a histoplas- 
m in skin test, the blood sample should be drawn 
first because the skin test may cause a positive 
complement-fixation test for up to 3 months and the 
appearance of the M band on an immunodiffusion
test for H. capsulatum .(1,7,8,26)
What can be done to reduce 
exposures to H. capsulatum?
Excluding a colony of bats or 
a flock of birds from a building
Although a primary focus of this booklet is how 
to protect the health of workers cleaning up accumu­
lated bat or bird manure, the best work practice is to 
prevent the accumulation of manure in the first place. 
Therefore, when a colony of bats or a flock of birds is 
discovered roosting in a building, immediate action 
should be taken to exclude the intruders by sealing all 
entry points. Any measure that might unnecessarily 
harm or kill a bat or bird should be avoided.
Before excluding a colony of bats or a flock of birds 
from a building, attention should be given to the 
possibility that flightless young may be present. In
the United States, this is an especially im portant 
consideration for bats from May through August.(94)
Ultrasonic devices and chemical repellents are inef­
fective for eliminating bats from a roosting area.(95) 
The m ost effective way o f excluding bats from an 
occupied roost involves following five basic steps to 
identify and seal entry and exit points.(94) Because 
some bat species are so small that they can squeeze 
through an opening as small as the diameter o f a 
dim e,(94) even the smallest hole should be sealed. 
W hen openings are inaccessible, installing and 
maintaining lights in  a roosting area will force bats 
to seek another daytime roosting site. Because of 
concerns for the welfare o f evicted bats, construct­
ing bat houses near former roosts has become a
common practice.(94,96)
In some buildings, extensive bat exclusion m ea­
sures may be more successful in  the late fall or 
winter months after a colony has m igrated to a 
warmer habitat or to another location for hiberna­
tion. In some regions o f the United States, bats may 
not migrate, but rather will hibernate in  the same 
building. Consequently, any work on a building that 
might disturb such a colony should be delayed until 
spring. Disturbing bats during hibernation is likely 
to result in their death.
Excluding birds from a building also involves 
blocking access to indoor roosts and nesting 
areas.(97) Because their food source is usually 
nearby, birds prevented from reentering a building 
will often complicate an exclusion by beginning to 
roost on window sills and ledges o f the building or 
others nearby. Visual deterrents (e.g., balloons, 
flags, lights, and replicas o f hawks and owls) and 
noises (e.g., gun shots, alarms, gas cannons, and 
fireworks) may scare birds away, but generally only
temporarily.(97)
Nontoxic, chemical bird repellents are available as 
liquids, aerosols, and nondrying films and pastes. 
Disadvantages o f these antiroosting materials are 
that some are messy and none are permanent. Even
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the most effective ones require periodic reapplica­
tion. More permanent repellents include mechanical 
antiroosting systems consisting o f angled and porcu­
pine wires made of stainless steel. These systems 
may require some occasional maintenance to clear 
nesting material or other debris from the wires.(97)
Pigeons can be controlled by capturing them  in 
traps placed near their roosting, loafing, or feeding 
sites.(97) Shooting birds, using contact poisons, and 
baiting with poisoned food should be used as last 
resorts and should only be done by qualified pest 
control specialists. Using such methods to kill nui­
sance birds may also require a special permit.
Posting health risk warnings
If a colony o f bats or a flock of birds is allowed to 
live in  a building or a stand o f trees, their manure 
will accumulate and create a health risk for anyone 
who enters the roosting area and disturbs the m ate­
rial. Once a roosting site has been discovered in  a 
building, exclusion plans should be made, and the 
extent o f contam ination should be determined. 
W hen an accumulation o f bat or bird manure is dis­
covered in  a building, removing the material is not 
always the next step. Simply leaving the material 
alone if  it  is in  a location where no hum an activity 
is likely may be the best course o f “action.”
Areas known or suspected o f being contaminated 
by H. capsulatum, such as bird roosts, attics, or 
even entire buildings that contain accumulations of 
bat or bird manure, should be posted with signs 
warning o f the health risk. Each sign should provide 
the name and telephone number o f a person to be 
contacted i f  there are questions about the area. In 
some situations, a fence may need to be built around 
a property or locks put on attic doors to prevent 
unsuspecting or unprotected  individuals from  
entering.
Communicating health risks to workers
Before an activity is started that may disturb any mate­
rial that might be contaminated by H. capsulatum,
workers should be inform ed in  writing o f the per­
sonal risk factors that increase an individual’s 
chances o f developing histoplasmosis. Such a w rit­
ten communication should include a warning that 
individuals with weakened im mune systems are at 
the greatest risk o f developing severe and dissem i­
nated histoplasmosis if  they become infected. These 
people should seek advice from their health care 
provider about whether they should avoid exposure 
to m aterials that m ight be contam inated with 
H. capsulatum. The fact sheet in  the appendix is one 
way o f conveying inform ation about histoplasm o­
sis; it can be distributed to workers during their haz­
ard communication training.
Controlling aerosolized dust when removing 
bat or bird manure from a building
The best way to prevent exposure to H. capsulatum  
spores is to avoid situations where material that 
m ight be contam inated can become aerosolized and 
subsequently inhaled. A brief inhalation exposure to 
highly contaminated dust may be all that is needed 
to cause infection and subsequent development of 
histoplasmosis. Therefore, work practices and dust 
control measures that eliminate or reduce dust gen­
eration during the removal o f bat or bird manure 
from a building will also reduce risks of infection 
and subsequent development o f disease. For exam ­
ple, instead o f shoveling or sweeping dry, dusty 
material,(39) carefully wetting it with a water spray 
can reduce the amount o f dust aerosolized during an 
activity. Adding a surfactant or wetting agent to the 
w ater m ight reduce further the am ount o f 
aerosolized dust. Once the material is wetted, it  can 
be collected in  double, heavy-duty plastic bags, a 
55-gallon drum, or some other secure container for 
immediate disposal. An alternative method is use of 
an industrial vacuum cleaner with a high-efficiency 
filter to “bag” contaminated material. Truck-mounted 
or trailer-mounted vacuum systems are recommended 
for buildings with large accumulations o f bat or bird 
manure. These high-volume systems can remove tons 
of contaminated material in  a short period. Using 
long, large-diameter hoses, such a system can also
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remove contaminated material located several stories 
above its waste hopper. This advantage eliminates the 
risk o f dust exposure that can happen when bags tear 
accidentally or containers break during their transfer 
to the ground.
The removal o f all material that m ight be contam i­
nated by H. capsulatum  from a building and im m e­
diate waste disposal will eliminate any further risk 
that someone m ight be exposed to aerosolized 
spores. Air sampling, surface sampling, or the use 
o f any other m ethod intended to confirm that no 
infectious agents remain following removal o f bat 
or bird manure is unnecessary in  m ost cases. 
However, before a removal activity is considered 
finished, the cleaned area should be inspected visu­
ally to ensure that no residual dust or debris 
remains.
Disinfecting contaminated material
Disinfectants have occasionally been used to treat 
contam inated soil and accumulations o f bat manure 
when removal was im practical or as a precaution 
before a removal process was started.(41,48-50,61,67) 
To date, formaldehyde solutions have been the only 
disinfectants proven to be effective for decontam i­
nating soil containing H. capsu la tum .(41,48-50) 
Exposures to form aldehyde through ingestion, 
inhalation, and skin and eye contact can cause a 
variety o f adverse health effects.(98) Several years 
ago, applicators exposed to formaldehyde during 
soil disinfection activities reported burning eyes 
and mucous membrane irritation.(48) Workers at 
another site experienced nausea and vomiting.(41)
Today, although a number o f EPA-registered fungi­
cidal products contain formaldehyde, none o f them 
is registered for use as a soil disinfectant. Thus, 
using a formaldehyde containing product to disin­
fect soil would be inappropriate. Furthermore, there 
is no product or chemical that is registered by the 
EPA that has the specific claim  o f being effective 
against H. capsulatum . A m anufacturer o f a product 
claim ing to d isinfect soil contam inated with 
H. capsulatum  will have to m eet the EPA’s regula­
tory requirements and complete the registration 
process.
Should an EPA-registered product become available 
to disinfect land contaminated by H. capsulatum , 
measures should be taken to ensure that the disin­
fectant penetrates deeply enough to contact all the 
soil containing H. capsulatum. W hile H. capsulatum  
was found in a blackbird roost at a depth of more 
than 12 inches,(99) soil saturation to a depth of 6  to 8 
inches will be sufficient for most disinfectant appli­
ca tions/38,4^  To evaluate a disinfectant’s effective­
ness, soil samples should be collected before and 
after an application and analyzed for H. capsulatum. 
The appropriate number of samples to be collected 
will vary depending upon the size of the proper- 
ty.(38,100) Each sampling location should be flagged 
or marked in  a way that will ensure that the same 
locations will be sampled after application of the 
disinfectant. A map of the treated area showing the 
approximate location of each sampling site will also 
be useful in  the event flags or markings are lost. 
After a disinfectant’s effectiveness has been docu­
mented— more than one application may be neces­
sary— additional tests for H. capsulatum  should be 
done periodically if the land remains idle.
Disposing of waste
Any material that m ight be contam inated with 
H. capsulatum  that is removed from a work site 
should be disposed of or decontaminated properly 
and safely and not merely moved to another area 
where it could still be a health hazard. Before an 
activity is started, the quantity of material to be 
removed should be estimated. (If the approximate 
volume of dry bat or bird manure in  a building is 
known, the approximate weight can be calculated 
using a conversion factor of 40 pounds per cubic 
foot.) Requirements established by local and state 
authorities for the removal, transportation, and dis­
posal of contaminated material should be followed. 
Arrangements should be made with a landfill oper­
ator concerning the quantity o f material to be dis­
posed of, the dates when the material will be deliv­
ered, and the disposal location. If local or state land­
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fill regulations define material contam inated with 
H. capsulatum  to be infectious waste, incineration 
or another decontamination method may also be 
required.
Controlling aerosolized dust during 
construction, excavation, and demolition
Dusts containing H. capsulatum  spores can be 
aerosolized during construction, excavation, or 
demolition. Once airborne, spores can be carried 
easily by wind currents over long distances. Such 
contaminated airborne dusts can cause infections not 
only in  persons at a work site, but also in  others 
nearby. Such activities were suggested as the causes 
of the three largest outbreaks of histoplasmosis ever 
recorded. All three outbreaks took place in 
Indianapolis, Indiana.(25,85,88,101) During the first 
outbreak, in  the fall o f 1978 and spring o f 1979, an 
estimated 120,000 people were infected, and 15 peo­
ple died. The second outbreak, in  1980, was similar 
to the first in the number of people affected. AIDS 
patients accounted for nearly 50% of culture-proven 
cases during the third outbreak, which began in  1988 
and lasted until 1993.(101)
Water sprays or other dust suppression techniques 
should be used to reduce the amount of dust 
aerosolized during construction, excavation, or 
dem olition in  regions where H. capsulatum  is 
endemic. During windy periods or other times when 
typical dust suppression techniques are ineffective, 
earthmoving activities should be interrupted. All 
earthmoving equipm ent (e.g., bulldozers, trucks, 
and front-end loaders) should have cabs with air- 
conditioning (if available) to protect their operators. 
Air filters on air-conditioners should be inspected 
on a regular schedule and cleaned or replaced as 
needed. During filter cleaning or replacem ent of 
exceptionally dusty air filters, respiratory protection 
should be worn by the maintenance person if there 
is a potential for the dust to be aerosolized. Beds of 
all trucks carrying dirt or debris from a work site 
should be covered, and all trucks should pass 
through a wash station before leaving the site. 
W hen at a dump site, a truck operator should ensure 
that all individuals in  the vicinity are in  an area
where they will not be exposed to dust aerosolized 
while the truck is emptied.
Water sprays and other suppression techniques may 
not be enough to control dust aerosolized during 
dem olition  of a building or other structure. 
Consequently, removal of accumulations of bird or 
bat manure before demolition may be necessary in 
some situations. Factors affecting decisions about 
pre-dem olition rem oval of such accum ulations 
include the quantity and locations of the material, 
the structural integrity or soundness of the building, 
weather conditions, proxim ity of the building to 
other buildings and structures, and whether nearby 
buildings are occupied by persons who may be at 
increased risk for developing symptomatic histo­
plasmosis (e.g., schools, day-care facilities, hospi­
tals, clinics, jails, and prisons).
City or county governments in  regions where 
H. capsulatum  is endemic should establish and 
enforce regulations concerning work practices that 
will control dust aerosolization at construction, 
excavation, and dem olition sites. However, even in 
regions where H. capsulatum  is not considered 
endemic, dust aerosolized during work activities in 
bird roosts has also resulted in  outbreaks of histo­
p la sm o sis /40,4^  C onsequently, regardless of 
whether a work site is in an endemic region, pre­
cautions should be taken at active and inactive bird 
roosts to prevent dust aerosolization.
Wearing personal protective equipment
Because work practices and dust control measures 
to reduce worker exposures to H. capsulatum  have 
not been fully evaluated, using personal protective 
equipm ent is still necessary during some activities. 
During removal of an accumulation of bat or bird 
m anure from an enclosed area such as an attic, dust 
control measures should be used, but wearing a 
NIOSH-approved respirator and other items of per­
sonal protective equipm ent is also recom m ended to 
reduce further the risk o f H. capsulatum  exposure.
For some jobs involving exposures to airborne dusts, 
working conditions have changed little over the
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years despite improvements in other aspects of the 
industry. For example, inhalation of dust aerosolized 
from the dirt floors o f chicken coops that contained 
H. capsulatum  spores was reported more than 40 
years ago as the cause o f clinical cases of histoplas­
mosis in workers.(73-77) As the poultry industry has 
grown, the old-style chicken coop has been replaced 
by larger housing facilities. In the United States in 
2002, approximately 82,400 farms produced eggs or 
poultry including layers, pullets, broilers, turkeys, 
ducks, and geese.(102) However, the floors o f most 
poultry houses are still dirt covered and provide an 
excellent medium for the growth of H. capsulatum . 
Ventilation systems in  poultry houses are not pri­
marily intended to reduce poultry workers’ expo­
sures to aerosolized dust, and dust measurements 
made during growing and catching chickens show 
that inhalation exposures of poultry workers to dust 
can be excessive.(103) Since ventilation systems 
designed especially to reduce airborne dust to “safe” 
levels in  poultry houses would likely be economi­
cally and mechanically impractical, wearing a respi­
rator is probably the most feasible method for pro­
tecting poultry workers.
Recommendations for selecting respirators to protect 
workers against inhalation exposures to airborne dust 
and H. capsulatum  are described next. Following 
that, recommendations for personal protective equip­
ment other than respirators are provided.
What are the advantages and 
disadvantages of various kinds of 
respirators for protecting workers 
against exposure to H. capsulatum?
Assigned protection factors
Respirators provide varying levels of protection, 
and people have developed histoplasmosis after dis­
turbing material contam inated with H. capsulatum  
despite wearing either a respirator or a m ask that 
they assumed would protect them .(60,71,104) Such 
unfortunate events demonstrate that when a respira­
tor is needed, it m ust be carefully selected with an 
understanding of the circumstances associated with
exposure to an airborne contam inant and the 
capabilities and limitations of the various kinds of 
respirators.
Because respirators provide different levels of pro­
tection, they are divided into classes, and each res­
pirator class has been assigned a protection factor to 
help compare its protective capabilities with other 
respirator classes. An assigned protection factor is a 
unitless number determined statistically from a set 
of experimental or workplace data. This factor is the 
m inimum level of protection expected for a sub­
stantial proportion (usually 95%) o f properly fitted 
and trained respirator users.(105)
W hen the effectiveness of a respirator is evaluated 
in  a workplace, a protection factor is calculated for 
each respirator wearer and respirator combination 
by dividing the air concentration of a challenge 
agent by the air concentration of that agent inside 
the respirator w earer’s facepiece, hood, or helmet. 
For example, if air sampling measurements show 
equal concentrations of a contam inant inside and 
outside a respirator w earer’s facepiece, then the res­
pirator provided no protection, and a protection fac­
tor o f 1 would be calculated. Likewise, a protection 
factor of 5 means that a respirator wearer was 
exposed to one-fifth (20%) o f the air concentration 
to which he or she would have been exposed if a 
respirator had not been used, a reduction of 80%. 
Similarly, a protection factor of 10 represents a one- 
tenth (10%) exposure (a 90% reduction), 50 repre­
sents a one-fiftieth (2%) exposure (a 98% reduc­
tion), and so on.
The assigned protection factors of respirators avail­
able for protecting workers against exposures to air­
borne materials contam inated with H. capsulatum  
range from 10 to 10,000.(106,107,108) Disposable res­
pirators and elastomeric half-facepiece respirators 
represent the low end o f the protection-factor scale. 
Self-contained breathing apparatuses operated in 
the pressure-demand mode, represent the high end. 
W ithin this range is a variety of negative-pressure, 
powered air-purifying, and supplied-air respirators
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that are available with half-facepiece, full face- 
piece, loose-fitting facepiece, hood, or helmet. 
Later in this section, the advantages and disadvan­
tages of these various respirators are described.
Respirator selection
Before the specific types o f respirators are 
described, it is im portant to understand the infor­
m ation that is usually needed to select a respirator 
for a particular activity.
The hazard ratio method, or the industrial hygiene 
method, is a quantitative method used most com ­
monly to select respirators for noninfectious 
aerosols, gases, and vapors. Using this method 
requires estimates of the air concentrations of a con­
taminant measured during a person’s work activities 
and knowledge of the established (or recommended) 
occupational exposure limits of that contaminant. A 
minimum level of respiratory protection is calculated 
by dividing the highest air concentration measure­
ment by the most protective occupational exposure 
limit of the contaminant. A respirator from the respi­
rator class having an assigned protection factor equal 
to or exceeding this value would then be selected. For 
example, assume a set of air samples collected dur­
ing a particular job resulted in  exposure estimates 
ranging from 8 to 50 milligrams per cubic meter 
(mg/m3) of sampled air for a contaminant having 
occupational exposure lim its o f 5 m g/m 3 and 
10 m g/m3. Given this information, a respirator 
with an assigned protection factor of at least 10 
(50 mg/m3 f  5 mg/m3 = 1 0 )  should be selected. 
However, applying the hazard ratio method to respi­
rator selection decisions for infectious aerosols is dif­
ficult and often impossible.(109)
Unfortunately, published air sampling data on 
H. capsulatum  spores are either outdated or too lim- 
ited,(68-70,76,80,110,111) and no numerical exposure 
limit exists for H. capsulatum . In situations such as 
this, when the important data needed for the hazard 
ratio method are either uncertain or unavailable, the 
expert opinion method is usually used.(109) This 
method is a qualitative approach to making decisions
about respirators based on the subjective professional 
judgm ent of one or more experts. Respirator selec­
tion is made after considering the characteristics of 
job activities that are recognized or anticipated to 
involve risks o f exposure to airborne contaminants; 
consideration of the properties of the specific agent 
involved and health effects of overexposure; and 
knowledge of the assigned protection factors, advan­
tages, and disadvantages o f various respirators.(109) 
In this application of the expert opinion method, cat­
egorical risk estimates were developed with the 
levels of recom m ended respiratory protection 
increasing as the perceived levels of exposure
increased.(109)
The follow ing respirator selection inform ation 
describes classes of respirators in  order of increas­
ing assigned protection factors. The assigned pro­
tection factors used here are from Table 1 of the 
N IO SH  Respirator Selection Logic.(106) Respirators 
that should be worn during work activities involv­
ing exposures to spore-contaminated airborne dusts 
range from disposable, filtering facepiece respira­
tors for low-risk situations (e.g., site surveys o f bird 
roosts) to full-facepiece, powered air-purifying res­
pirators for extremely dusty work (e.g., removing 
accumulated bird or bat manure from an enclosed 
area such as an attic).
Regardless of which respirator is selected, the 
device should be NIOSH-certified and used in  the 
context of a respiratory  pro tection program . 
Im portant components of such a program  are face- 
piece fit-testing, respirator maintenance, user train­
ing, medical evaluation of users, respiratory protec­
tion program evaluation, and recordkeeping.(112,113)
Disposable and elastomeric, 
half-facepiece, air-purifying respirators 
(assigned protection factor: 10)
A half-facepiece respirator covers the wearer's nose 
and mouth. Because inhalation creates a slight neg­
ative pressure inside the facepiece of non-powered, 
air-purifying respirators with respect to outside, 
these respirators are also called negative-pressure
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respirators. During inhalation, contam inated air can 
easily enter the facepiece o f a negative-pressure res­
pirator at gaps between the facepiece and the respi­
rator wearer's face. Therefore, a complete face-to- 
facepiece seal is essential for good protection. The 
findings o f a study to evaluate faceseal leaks o f an 
elastomeric half-facepiece respirator showed that 
89% o f the leaks occurred at the nose or chin or 
were m ultiple leaks that included these loca- 
tions.(114) Facial hair (even the stubble o f a few 
days’ growth), absence o f one or both dentures, and 
deep facial scars can also prevent a complete seal.
W hereas elastomeric half-facepiece respirators con­
sist o f a reusable elastomeric or rubber facepiece 
and replaceable filters, most disposable respirators 
are filtering facepieces in  which the facepiece is the 
dust filter. Disposable respirators and replaceable 
filters can be used until they are difficult to breathe 
through, damaged, or malodorous.
A disadvantage o f any negative-pressure, air-purify­
ing respirator is that resistance to inhalation 
increases as the filters load with dust. For dispos­
able respirators without exhalation valves, filter 
loading increases resistance during exhalation as 
well as inhalation. This effect, com bined with the 
warm, m oist air inside the facepiece, is so uncom ­
fortable for some people that they do not wear a res­
pirator as frequently as they should, or they stop 
wearing one entirely.
As o f July 10, 1995, NIOSH began certification of 
negative-pressure, air-purifying particulate filters 
under new regulations (42 CFR Part 84).(115) All par­
ticulate-filtering respirators certified by NIOSH 
under previous regulations (30 CFR Part 11) were no 
longer sold after July 10, 1998, and only Part 84 par­
ticulate respirators are now available. Part 84 partic­
ulate respirators have the prefix TC-84A. Part 84 par­
ticulate filters are divided into nine classes, and filters 
from any class can be selected for protection against 
inhalation o f H. capsulatum  spores. A filter’s class 
(e.g., N-95) and “NIOSH” are marked on the face­
piece, exhalation valve cover, or head straps of dis­
posable respirators, and on filter cartridges and car­
tridge boxes.
Although Part 84 improved the requirements for par­
ticulate filters, the facepiece fitting characteristics of 
all particulate respirators became exempt from eval­
uation as a condition o f NIOSH certification.(116) 
Thus, only respirators with good fitting characteris­
tics should be purchased, and it is essential that 
workers are assigned respirators based on the results 
o f facepiece fit-testing. To aid in the selection of fil­
tering facepiece respirators for fit testing, studies 
have been published on the fitting characteristics of 
some o f them .(116,117)
The type of head straps on the various disposable 
and elastomeric half-facepiece respirators is an 
important but frequently overlooked consideration.
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Head strap tension is important for achieving a 
complete face-to-facepiece seal without sacrificing 
comfort. Elastomeric facepieces have adjustable 
straps, which should allow a respirator wearer to 
make a complete, yet comfortable, facepiece seal. 
On the other hand, not all disposable respirators 
have adjustable straps; some simply have fixed- 
length elastic bands. M ost disposable respirators 
certified under Part 84, do not have adjustable straps, 
only elastic bands. Research has not been done to 
evaluate whether the facepiece fits o f respirators 
with adjustable straps differ significantly from those 
o f respirators with elastic bands. However, a respira­
tor user should be aware that the fit and comfort o f a 
disposable respirator with elastic bands might differ 
from one with adjustable straps.
In dusty conditions, repeated exposure o f the eyes 
to dust increases the risk  for injury and disease. 
M ost dust particles entering a person's eyes will be 
washed out by tears, but some particles can be 
retained, particularly within the m argin o f the 
upper eyelid. Depending on their size, shape, and 
composition, these particles can becom e em bedded 
in  the surface o f the cornea or sclera, where they 
cause irritation and then reddening o f the surface. 
If  not removed, such particles m ay produce eye 
infections.(118) Therefore, a half-facepiece respira­
tor is a poor choice for use in  dusty conditions. 
W hile wearing eyecup goggles may provide some 
eye protection, they are not airtight and do not 
com pletely prevent dust exposure. Furthermore, 
goggles may interfere with a respirator’s fit. For 
these reasons, a full-facepiece respirator is a better 
alternative when a person’s eyes are at risk o f expo­
sure to airborne dusts.
Because their assigned protection factors are lower 
than those o f other respirator types, the use o f dis­
posable or elastomeric half-facepiece respirators 
should be lim ited to situations where risks are low 
for inhaling material that might be contam inated 
with H. capsulatum  spores. Situations that could be 
considered low risk include site surveys o f bird 
roosts, collecting soil samples, or maintenance on 
filters of earthmoving equipment. However, during
earthmoving activities at bird roosts or other work 
sites where the soil is known to be heavily contam ­
inated by H. capsulatum, air-purifying, half-facepiece 
respirators should be worn by equipment operators to 
supplement dust suppression methods and the use of 
equipment with cabs.
Powered air-purifying respirators 
with loose-fitting facepiece and 
continuous-flow, supplied-air 
respirators with hood or helmet 
(assigned protection factor: 25)
A powered air-purifying respirator uses a small 
battery-operated blower to draw dusty air through 
attached filters and provides clean air at a constant 
flow rate o f 170 liters per minute (L/min). This flow 
rate is usually greater than a w earer’s breathing rate. 
Consequently, gaps in  a face-to-facepiece seal will 
leak air outward rather than inward. Another advan­
tage of these respirators is that they provide built-in 
eye protection. They are also the only respirators 
that adequately protect bearded workers.
Because powered air-purifying respirators cause 
almost no breathing resistance, the discomfort that 
some people experience while wearing a negative- 
pressure respirator is reduced. Interviews with 117 
agricultural workers (53 swine farmers, 46 grain 
handlers, and 18 poultry farmers), found that pow­
ered air-purifying respirators w ith loose-fitting 
facepieces were rated best over disposable and elas- 
tomeric half-facepiece respirators for breathing ease, 
communication ease, skin comfort, and in-facepiece 
temperature and humidity.(119) Disposable respira­
tors were rated best for weight and convenience.
Powered air-purifying respirators with particulate 
filters approved by NIOSH under the regulations of 
42 CFR Part 84 have the prefix TC-84A. Only pow­
ered air-purifying respirators with high-efficiency 
filters are approved by NIOSH under Part 84.
Supplied-air respirators are not air-purifying types, 
but deliver breathing air from an air com pressor or 
compressed air cylinder through a pressurized hose
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to the facepiece. Continuous-flow, supplied-air 
respirators with loose-fitting facepieces also pro­
vide a minimum air flow rate o f 170 L/min. The 
maximum air flow rate o f a continuous-flow sup- 
plied-air respirator may not exceed 425 L/min. Air 
supply hoses are available in a variety o f lengths up 
to a maximum of 300 feet. All NIOSH-approved, 
supplied-air respirators have the prefix TC-19C.
An advantage of a supplied-air respirator is that the 
source o f the breathing air does not depend upon fil­
ters to purify ambient air. An advantage o f continu- 
ous-flow, supplied-air respirators is that when an 
activity involves work in  a hot environment, such as 
an attic or a chicken house in the summer, a vortex 
tube can be added to the device that will cool the air 
flowing to the respirator wearer. A disadvantage of 
a supplied-air respirator is that if  its air supply hose 
is too short, then mobility of the respirator wearer 
will be restricted. Also, in  some situations (in attics 
or on elevated structures for example), the trailing 
hose of a supp lied-air resp ira to r can  be a tr ip ­
ping hazard.
W hile the respirators described in  this section have 
higher assigned protection factors than disposable 
or elastomeric half-facepiece respirators, they may 
not provide enough protection in  extremely dusty 
conditions where air concentrations o f H. capsula­
tum  spores may be high, especially in  enclosed 
spaces. Examples o f activities for which respirators 
w ith  higher assigned protection factors may be 
more im portant include cleaning chim neys(66) and 
working in  attics(58,61,67) and poultry houses.(74-77)
Air-purifying, full-facepiece respirators; 
powered air-purifying respirators with 
half-facepiece or full facepiece; and 
continuous-flow, supplied-air respirators 
with half-facepiece or full facepiece 
(assigned protection factor: 50)
A full-facepiece respirator extends from the fore­
head to under the chin. It also has the built-in bene­
fit of providing eye protection as well as respiratory
protection. As with other negative-pressure respira­
tors, a complete face-to-facepiece seal is essential 
for good protection. However, partly because a good 
fit is easier with a full-facepiece, negative-pressure 
respirator, this type has a higher assigned protection 
factor than half-facepiece types. Fogging o f a full- 
facepiece lens can obstruct vision, but this problem 
is preventable by adding a nosecup inside the face- 
piece. Antifogging agents in sticks and sprays are 
also available, but vary in  their effectiveness. Most 
respirator manufacturers sell, but seldom advertise, 
packages of thin plastic covers for protecting the 
lens of a full-facepiece respirator. Available at a m in­
im um  charge, these replaceable covers prevent 
scratching o f the permanent lens and prolong its life. 
NIOSH-approved, air-purifying, full-facepiece res­
pirators for protection against particulate exposures 
have the prefix TC-84A.
■
Full-Facepiece Respirator
The minimum air flow rate for both a powered air- 
purifying respirator and a continuous-flow, sup- 
plied-air respirator with a half-facepiece or full 
facepiece is 115 L/min. As with other continuous- 
flow, supplied-air respirators, the maximum air 
flow for these devices may not exceed 425 L/min. 
An air flow o f 115 L/m in is probably sufficient for 
most work activities involving possible exposures 
to aerosolized H. capsulatum  spores. However, 
breathing rates during activities requiring heavy 
exertion may produce peak inhalation air flows 
exceeding 115 L/m in. Consequently, someone
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doing heavy work could interm ittently overbreathe 
the respirator’s air flow, resulting in brief periods 
when contam inated air could enter the facepiece at 
gaps in the face-to-facepiece seal.
Powered Air-Purifying Respirator
The full-facepiece respirators described in this sec­
tion are recommended as the minimum respiratory 
protection in  extremely dusty conditions where high 
concentrations of H. capsulatum  spores could be 
aerosolized, especially in  enclosed areas. Air-purify­
ing, full-facepiece respirators have been recom ­
mended for poultry workers based on the results of 
air sam pling during chicken-catching activities 
inside poultry houses.(103) As mentioned earlier, 
half-facepiece respirators provide no eye protection, 
and even the concurrent use of eyecup goggles is 
probably impractical in  extremely dusty working 
conditions. Unless the results o f quantitative tests 
suggest that a person wearing an air-purifying, full- 
facepiece respirator can achieve an outstanding face- 
piece seal, a powered air-purifying respirator with a 
full facepiece should be chosen for extrem ely 
dusty work.
A powered air-purifying respirator with a full face- 
piece should also be the minimum respiratory pro­
tection worn by someone entering an enclosed area 
in  which the amount of bat and bird manure conta­
m ination is unknown. A less protective respirator 
should be worn only when a site has been evaluated 
as having a low risk for inhalation exposure to m ate­
rial that might be contaminated with H. capsulatum .
Pressure-demand, supplied-air 
respirators with full facepiece 
(assigned protection factor: 2,000)
The air regulator o f a pressure-demand, supplied-air 
respirator is designed to maintain positive facepiece 
pressure even during heavy physical activity. This 
type o f respirator has the same advantages and dis­
advantages as other supplied-air respirators, except 
that a vortex tube cannot be used to cool the air 
delivered to the respirator wearer.
Supplied-air Respirator
Pressure-demand, self-contained 
breathing apparatuses (SCBA) and 
combination pressure-demand, supplied- 
air respirators with auxiliary SCBA 
(assigned protection factor: 10,000)
Because the wearer o f a self-contained breathing 
apparatus (SCBA) carries his or her own air supply, 
a pressure-demand SCBA has an advantage of 
allowing greater mobility than a supplied-air respi­
rator. However, not everyone may agree that this is 
a significant advantage, since these devices can 
weigh as m uch as 40 pounds. Open-circuit SCBAs, 
like those worn by firefighters, are available with 
rated service lives o f 15, 30, 45, and 60 minutes. 
Auxiliary SCBAs for combination units are avail­
able that have service lives ranging from 3 to 60 
minutes. Closed-circuit SCBAs, like those worn by 
members of mine rescue teams, are available with 
rated service lives from 1 to 4 hours.
SCBAs have been recom m ended fo r use by 
w orkers in  areas contam inated with H. capsulatum
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spores,(100) but they are too impractical for most sit­
uations where respirators are needed to protect 
against the inhalation o f H. capsulatum  spores. 
Another disadvantage, particularly during removal 
jobs that may take a long time, is that SCBA can be 
used for only 30 to 60 minutes. Thus, frequent work 
stoppages are needed to change air cylinders. Also, 
an adequate supply o f full cylinders is 
needed at a work site.
Combination pressure-demand, supplied-air respira­
tors with auxiliary SCBA would be useful for very 
dusty work environments. The auxiliary SCBA 
could be used to escape to an area of fresh air when­
ever delivery of breathing air is interrupted. All 
NIOSH-approved SCBA and combination SCBA 
and supplied-air respirators have the prefix TC-13F.
Summary
Because of the need for mobility, most decisions 
concerning the appropriate respirator for protecting 
against inhalation exposure to material that might 
contain H. capsulatum  spores will involve choosing 
the most appropriate air-purifying respirator. To 
help the reader with this decision, Table 1 sum m a­
rizes the advantages and disadvantages o f air-puri­
fying respirators and their costs.
What personal protective 
equipment other than respirators 
should workers wear?
Disposable protective clothing and shoe coverings 
should be worn whenever regular work clothing and
shoes might be contaminated with dust containing 
H. capsulatum  spores.(44,57,58) Wearing such cloth­
ing can reduce or eliminate the likelihood o f trans­
ferring spore-contaminated dust to places away from 
a work site, such as a car or home. W hen spore-con­
taminated material is likely to fall from overhead, 
workers should wear disposable protective clothing 
with hoods.(58) Workers should wear disposable 
shoe coverings with ridged soles made of slip-resis­
tant material to reduce the likelihood of slipping on 
wet or dusty surfaces. After working in  a spore-con­
taminated area and before removing respirators, 
workers should remove all protective clothing and 
shoe coverings and seal them in heavy-duty plastic 
bags to be disposed o f in  a landfill.(120)
Since the personal protective equipment described 
above can be more insulating than regular work 
clothing, sweat evaporation may be im peded during 
some work activities. Therefore, precautions may 
need to be taken to control heat stress. For example, 
when protective clothing is needed, wearing a light­
weight, cotton coverall would create less of a heat- 
stress risk for a worker than wearing a chemical- 
resistant suit. Additionally, workers should know 
the symptoms of heat-stress-related illnesses and be 
able to take appropriate measures to ensure that 
such illnesses do not occur. Some jobs may have 
such a significant risk of heat stress that they should 
be scheduled only when ambient temperatures are 
relatively cool.
Wearing chemical-resistant gloves will seldom be 
necessary when working in  a spore-contaminated 
area. If they are worn, care should be taken to avoid 
the harmful effects on the skin that can result from 
occlusion (physical process of trapping a material 
against the skin), sweating, and m aceration (soften­
ing and breaking down o f tissue).(121,122) A thin cot­
ton glove can be worn inside a chemical-resistant 
glove to protect against dermatitis, which can occur 
from prolonged skin exposure to moisture in  gloves 
caused by perspiration. Because wearing chemical- 
resistant gloves can aggravate existing dermatitis, 
their use by workers having dermatitis may not be 
appropriate. The m edical treatment of workers
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Filtering facepiece 10 -  lightweight -  provides no eye protection $0.70 to $10
(Disposable) -  no maintenance or cleaning -  can add to heat burden
needed -  inward leakage at gaps in face seal
-  no effect on mobility -  some do not have adjustable head straps
■ difficult for a user to do a seal check
■ level of protection varies greatly 
among models
■ communication may be difficult
■ fit testing required to select proper 
facepiece size
■ some eyewear may interfere with the fit
Elastomeric 10 -  low maintenance
half-facepiece -  reusable facepiece and replaceable
filters and cartridges
-  no effect on mobility
■ provides no eye protection
■ can add to heat burden
■ inward leakage at gaps in face seal
■ communication may be difficult
■ fit testing required to select proper 
facepiece size
■ some eyewear may interfere with the fit
facepiece: $12 to $35 
filters: $4 to $8 each
Powered with 25 -  provides eye protection
loose-fitting -  protection for people with beards,
facepiece missing dentures or facial scars
-  low breathing resistance
-  flowing air creates cooling effect
-  face seal leakage is generally 
outward
-  fit testing is not required
-  prescription glasses can be worn
-  communication less difficult than 
with elastomeric half-facepiece or 
full-facepiece respirators
-  reusable components and 
replaceable filters
■ added weight of battery and blower
■ awkward for some tasks
■ battery requires charging
■ air flow must be tested with flow device 
before use
unit: $400 to $1000 
filters: $10 to $30
Elastomeric 50 -  provides eye protection -  can add to heat burden facepiece: $90 to $240
full-facepiece with -  low maintenance -  diminished field-of-vision compared to filters: $4 to $8 each
N-100, R-100, or -  reusable facepiece and replaceable half-facepiece nose cup: $30
P-100 filters filters and cartridges -  inward leakage at gaps in face seal
-  no effect on mobility -  fit testing required to select proper
-  more effective face seal than that facepiece size
of filtering facepiece or elastomeric -  facepiece lens can fog without nose cup
half-facepiece respirators or lens treatment
-  spectacle kit needed for people who
wear corrective glasses
Powered with 50 -  provides eye protection with -  added weight of battery and blower unit: $500 to $1000
tight-fitting full-facepiece -  awkward for some tasks filters: $10 to $30
half-facepiece -  low breathing resistance -  no eye protection with half-facepiece
or full-facepiece -  face seal leakage is generally 
outward
-  flowing air creates cooling effect
-  reusable components and 
replaceable filters
-  fit testing required to select proper 
facepiece size
-  battery requires charging
-  communication may be difficult
-  spectacle kit needed for people who 
wear corrective glasses with full 
face-piece respirators
-  air flow must be tested with flow device 
before use
Note: The assigned protection factors in this table are from the NIOSH Respirator Selection Logic.(106) When the table was prepared, OSHA had 
proposed amending the respiratory protection standard to incorporate assigned protection factors.(107) The Internet sites of NIOSH (www.cdc.gov/niosh) 
and OSHA (www.osha.gov) should be checked for the current assigned protection factor values.
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having dermatitis and decisions about their use of 
gloves should be supervised by a physician experi­
enced with occupational skin diseases.(122)
What other infectious agents are 
health risks for workers who disturb 
accumulations of bat droppings or 
bird manure?
In addition to H. capsulatum, inhalation exposure to 
Cryptococcus neoformans may also be a health risk 
for workers in  environments containing accum ula­
tions of bat droppings or bird manure. Inhalation 
exposures to Chlamydia psittaci have occurred 
occasionally  in  environm ents containing the 
m anure of certain birds, and exposure to the rabies 
virus is a health risk for workers who m ust handle 
dead bats.
Cryptococcus neoformans
C. neoformans is the infectious agent o f the fungal 
disease cryptococcosis. Formerly a rare disease, the 
incidence of cryptococcosis has increased in  recent 
years because o f its frequent occurrence in  AIDS 
patients.(123-127) C. neoformans and H. capsulatum  
are only two o f the more than 100 microorganisms 
that have been reported with increased frequency 
among HIV-infected persons, and cryptococcosis 
and histoplasmosis are both classified as AIDS- 
indicator opportunistic infectious diseases.(127) In 
1997, the USPHS/IDSA Prevention of Opportunistic 
Infections Working Group recommended that HIV- 
infected persons should avoid “sites that are likely to 
be heavily contaminated with C. neoformans (e.g., 
areas heavily contam inated w ith pigeon drop- 
pings).”(128) However, evidence is lacking that con­
tam inated bird manure is the primary environmen­
tal source o f exposure to C. neoformans in most 
cases of cryptococcosis among HIV-infected per- 
sons.(125) Thus, the 2001 USPHS/IDSA guidelines 
do not include the pigeon droppings example.(89) 
An HIV-infected person should consult his or her 
health care provider about the appropriate exposure 
precautions to be taken for any activity having a 
risk o f exposure to C. neoformans.
C. neoformans uses the creatinine in  avian feces as 
a nitrogen source. It gains a competitive advantage 
over other microorganisms and multiplies exceed­
ingly well in  dry bird manure accumulated in places 
that are not in  direct sunlight.(38,123) This m icroor­
ganism is commonly associated with old pigeon 
manure, but it has also been recovered from dried 
excreta of chickens, sparrows, starlings, and other 
birds.(123) As with H. capsulatum, C. neoformans 
has not been found in fresh bird droppings, but it 
has been cultured from the beaks and feet of 
pigeons.(123) Bats have been shown to be infected 
with C. neoformans,(129) and both C. neoformans 
and H. capsulatum  have been recovered from bat 
dropping samples collected at the same site.(66,67) 
However, it should not be assumed that a worker’s 
illness is cryptococcosis when only C. neoformans 
is recovered from environmental samples collected 
from suspected sources o f exposure. C. neoformans 
has been recovered from  environm ents where 
H. capsulatum  was not recovered, even though sick 
workers were diagnosed from the results of clinical 
tests as having histoplasm osis.(61,86)
Unlike outbreaks of other mycoses, outbreaks of 
cryptococcosis traced to environmental sources 
have not been described, and it is presumed that 
most people can overcome most inhalation expo­
sures to C. neoformans.(124) More detailed inform a­
tion about C. neoformans and cryptococcosis is 
available in  other reports.(123,124,130-133) Work prac­
tices described previously in  this docum ent for con­
trolling exposures to H. capsulatum , including the 
use o f personal protective equipment, will also pro­
tect against inhalation exposures to C. neoformans 
and other microorganisms.
Chlamydia psittaci
Psittacosis is caused by a bacterium (C. psittaci) 
rather than a fungus, but it is another infectious dis­
ease that people can develop after disturbing and 
inhaling contam inated b ird  m anure. W hile 
C. psittaci has been isolated from approximately 
130 avian species,(134) m ost hum an infections result 
from inhalation exposures to aerosolized urine,
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respiratory secretions, or dried manure of infected 
psittacine (parrot-type) birds, such as cockatiels, 
parakeets, parrots, and macaws; avian chlamydiosis 
is d iagnosed less frequently  in  canaries and 
finches.(135) Among caged, nonpsittacine birds, 
infection with C. psittaci occurs most frequently in 
pigeons, doves, m ynah birds. Psittacosis in  humans 
has occasionally been associated with exposures to 
infected pigeons, turkeys, chickens, ducks, pheas­
ants, and geese, or their m anure.(83,134,136-138)
According to the C D C ’s annual summaries o f noti­
fiable diseases, 904 cases o f psittacosis in  humans 
were reported to CDC from 1988 through 2003 
(range: 15 cases in  2003 to 116 cases in 1989). 
Psittacosis is not a notifiable disease in  all states, 
and thus, the actual num ber of cases is likely to be 
higher. Also, the num ber of cases may be under­
estim ated because the disease is difficult to diag­
nose and cases often go unreported.(135) The sever­
ity of disease experienced by an infected person can 
range from asymptomatic to severe systemic dis­
ease with pneumonia; death occurs in  less than 1% 
o f properly treated patients.(135)
The National Association of State Public Health 
V eterinarians has recom m ended that workers 
should wear protective clothing, gloves, and a res­
pirator with filters having an N-95 rating or higher 
when cleaning cages or handling birds infected with 
C. psittaci.(135)
Rabies
Rabies is a viral disease caused by infection o f the 
central nervous systems o f wild and domestic ani­
mals and hum ans.(139) The initial symptoms of 
hum an rabies resemble those of other systemic viral 
infections, including fever, headache, malaise, and 
disorders of the upper respiratory and gastrointesti­
nal tracts.(140) Recognizing that a person has been 
exposed to the virus and prompt treatment are 
essential for preventing rabies. For once clinical 
symptoms have begun, there is no treatment for 
rabies and almost all patients will die from the dis­
ease or its complications within a few weeks of 
onset.(139,140)
In the United States, wild animals (especially bats, 
raccoons, skunks, coyotes, and foxes) are the most 
im portant sources o f rabies in fection .(141-143) 
Indigenous rabid bats have been reported from 
every state except Hawaii.(141-143) Individual bats 
from most of the estim ated 41 bat species in  the 
United States have been found to be infected with 
rabies virus.(145) Rabies virus associated with insec­
tivorous bats (those that feed principally on insects) 
accounted for 32 of the 35 indigenous rabies cases 
in  humans in  the United States between 1958 and 
2000.(145)
Rabies is transm itted via an infected anim al’s bite 
or by contamination of abrasions, open wounds, 
mucous membranes or theoretically, scratches, by 
infectious material such as saliva.(144) Contact with 
the blood, urine, or manure of a rabid animal is not 
a risk  factor for contracting rab ies.(144) 
Consequently, workers exposed to accumulations of 
bat droppings in environments from which bats 
have been excluded have no rabies risk. Although 
spelunkers seldom have direct contact with bats, 
they are included in  a frequent-risk category by 
CDC because of potential for bite, nonbite, or 
aerosol exposure to the rabies virus.(144) Two fatal 
cases of rabies in  humans have been attributed to 
possible airborne exposures in  caves containing 
m illions o f free-tailed  b a ts .(144) In addition, 
between 1990 and 2000, a bite was documented in 
only 2 of the 24 U.S. hum an rabies cases caused by 
bat-associated rabies virus variants.(146) This sug­
gests “that transm ission o f rabies virus can occur 
from minor, seemingly unimportant, or unrecog­
nized bites from bats.”(144) W hile aerosol transm is­
sion o f the rabies virus from bats to people is theo­
retically possible under extraordinary conditions, 
the risk is otherwise negligible.
The percentage of rabid bats in any colony is prob­
ably low (0.5% or less(95)). However, a dead bat 
should still never be picked up with bare hands 
since its death may have been caused by an infec­
tious agent. The rabies virus can remain infectious in 
a carcass until decomposition is well advanced.(94) 
Thus, whenever possible, a shovel or some other
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tool should be used to pick up and dispose of a dead 
bat. If  a dead bat must be handled, wearing heavy 
work gloves should minimize the risk of disease 
transm ission because of an accidental scratch from 
the bat’s teeth or by contamination of existing 
scratches or abrasions on a worker’s hands.
Where can I get more information 
about infectious diseases and 
answers to questions about worker 
health and safety issues?
This guidance docum ent was prepared by the 
National Institute for Occupational Safety and 
H ealth  (NIOSH) and the N ational C enter for
Infectious Diseases (NCID), both o f the Centers for 
Disease Control and Prevention. For more inform a­
tion about histoplasmosis or other infectious dis­
eases, please contact your physician, your local 
health department, or NCID in Atlanta, Georgia, 
N C ID ’s Internet address is http://www.cdc.gov/nci- 
dod/. For more inform ation about worker health and 
safety precautions during disturbances o f soil, bat 
droppings, or bird manure that m ight be contam i­
nated with H. capsulatum spores, call NIOSH in 
Cincinnati, Ohio, at (800) 356-4674. A  list of non­
powered, air-purifying respirators that have been 
tested and approved by NIOSH under 42 CFR Part
84 regulations can be found on the NIOSH Internet 
home page, http://www.cdc.gov/niosh.
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Histoplasmosis is an infectious disease caused by 
inhaling spores of a fungus called Histoplasma  
capsulatum . Histoplasmosis is not contagious; it 
cannot be transmitted from an infected person or 
animal to someone else.
What are the symptoms of histoplasmosis?
Histoplasmosis primarily affects a person’s lungs, 
and its symptoms vary greatly. The vast majority of 
infected people are asymptomatic (have no appar­
ent ill effects) or they experience symptoms so 
mild they do not seek medical attention. If symp­
toms do occur, they will usually start within 3 to 17 
days after exposure, with an average of 10 days. 
Histoplasmosis can appear as a mild, flu-like respi­
ratory illness and has a combination of symptoms, 
including malaise (a general ill feeling), fever, 
chest pain, dry or nonproductive cough, headache, 
loss of appetite, shortness of breath, joint and mus­
cle pains, chills, and hoarseness. A chest X-ray of 
a person with acute pulmonary histoplamosis will 
commonly show a patchy pneumonitis, which 
eventually calcifies. Chronic lung disease due to 
histoplasmosis resembles tuberculosis and can 
worsen over months or years. The most severe and 
rare form of this disease is disseminated histoplas­
mosis, which involves spreading of the fungus to 
other organs outside the lungs.
Who can get histoplasmosis?
Anyone working at a job or present near activities 
where material contaminated with H. capsulatum  
becomes airborne can develop histoplasmosis if 
enough spores are inhaled. After an exposure, how 
ill a person becomes varies greatly and most likely 
depends on the number of spores inhaled and a per­
son’s age and susceptibility to the disease. The 
number of inhaled spores needed to cause disease 
is unknown. Children younger than 2 years of age, 
persons with compromised immune systems, and
older persons, in particular those with underlying 
illnesses such as diabetes and chronic lung disease, 
are at increased risk for developing symptomatic 
histoplasmosis.
People with weakened immune systems are at great­
est risk for developing severe and disseminated 
histoplasmosis. Included in this high-risk group are 
persons with AIDS or cancer and persons receiving 
cancer chemotherapy; high-dose, long-term steroid 
therapy; or other immuno-suppressive drugs.
Before 2000, a person could learn from a histo- 
plasmin skin test whether he or she had been pre­
viously infected by H. capsulatum . However, the 
manufacturing of histoplasmin was discontinued in 
2000, and the skin testing reagents were still 
unavailable in 2004. A previous infection can pro­
vide partial immunity to reinfection. Since a posi­
tive skin test does not mean that a person is com­
pletely immune to reinfection, appropriate expo­
sure precautions should be taken regardless of a 
worker’s past skin-test status whenever distur­
bances of materials that might be contaminated 
with H. capsulatum  occur.
What is the treatment fo r histoplasmosis?
Mild cases of histoplasmosis are usually resolved 
without treatment. For severe cases, special anti­
fungal medications are needed to arrest the disease. 
Disseminated histoplasmosis is fatal if untreated, 
but death can also occur in some patients even 
when medical treatment is received.
Where are H. capsulatum spores found?
H. capsulatum  grows in soils throughout the world. 
In the United States, the fungus is endemic (more 
prevalent) and the proportion of people infected by 
H. capsulatum  is higher in central and eastern 
states, especially along the Ohio and Mississippi 
River valleys. The fungus seems to grow best in 
soils having a high nitrogen content, especially
those enriched with bat droppings or bird manure. 
Disturbances of contaminated material cause small 
H. capsulatum  spores to become airborne or 
aerosolized. Once airborne, spores can easily be car­
ried by wind currents over long distances.
How can someone know if  soil or 
droppings are contaminated with 
H. capsulatum spores?
To learn whether soil or droppings are contaminated 
with H. capsulatum  spores, samples must be collected 
and cultured. Presently, the method used to isolate 
H. capsulatum  is expensive and requires several 
weeks to complete. If not enough samples are 
collected, small but highly contaminated areas can 
be overlooked. Until a less expensive and more 
rapid method is available, testing samples for 
H. capsulatum  will continue to be impractical for 
most situations. Consequently, when thorough test­
ing is not done, the safest approach is to assume soil 
in endemic regions and any accumulations of bat 
droppings or bird manure are contaminated with 
H. capsulatum  and take appropriate exposure 
precautions.
What jobs and activities have risks 
fo r  exposure to H. capsulatum spores?
Below is a partial list of occupations and hobbies 
with risks for exposure to H. capsulatum  spores. 
Appropriate exposure precautions should be taken 
by these people and others whenever contaminated 
soil, bat droppings, or bird manure is disturbed.
I  Bridge inspector or painter 
I  Chimney cleaner 
I  Construction worker 
I  Demolition worker 
I  Farmer 
I  Gardener
I  Heating and air-conditioning system installer or 
service person
I  Microbiology laboratory worker
I  Pest control worker
I  Restorer of historic or abandoned buildings 
I  Roofer
I  Spelunker (cave explorer)
How can exposure to H. capsulatum 
be controlled and histoplasmosis 
prevented?
The best way to prevent exposures to H. capsulatum  
spores is to avoid situations where material that 
might be contaminated can become aerosolized and 
subsequently inhaled. This is especially important 
for persons with weakened immune systems.
Dust suppression methods, such as carefully wetting 
with a water spray, may be useful for reducing the 
amount of material aerosolized during an activity. 
For some activities, such as removing an accumula­
tion of bat droppings or bird manure from an 
enclosed place such as an attic, wearing a 
NIOSH-approved respirator and other items of per­
sonal protective equipment may be needed to further 
reduce the risk of H. capsulatum  exposure. However, 
only persons trained in the proper selection and use 
of personal protective equipment should undertake 
work where this equipment is needed
Disinfectants have occasionally been used to treat 
soil and accumulated bat manure when removal was 
impractical or as a precaution before a removal 
process was started. There is no product or chemical 
that is registered by the EPA that has the specific 
claim of being effective against H. capsulatum . A 
manufacturer of a product claiming to disinfect soil 
contaminated with H. capsulatum  will have to meet 
the EPA’s regulatory requirements and complete the 
registration process.
Where can I get more information 
about histoplasmosis?
This histoplasmosis fact sheet was prepared by the 
National Institute for Occupational Safety and Health 
(NIOSH) and the National Center for Infectious 
Diseases (NCID), both of the Centers for Disease 
Control and Prevention. For answers to other ques­
tions about histoplasmosis or histoplasmin skin-test­
ing, please contact your physician, your local health 
department, or NCID in Atlanta, Georgia. NCID’s 
Internet address is http://www.cdc.gov/ncidod/. For 
other questions about worker health and safety pre­
cautions during disturbances of soil, bat droppings, or 
bird manure that might be contaminated with 
H. capsulatum  spores, call NIOSH in Cincinnati, 
Ohio, at (800) 356-4674.
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HISTOPLASMOSIS
¿Qué es la histoplasmosis?
La histoplasmosis es una enfermedad infecciosa 
causada por la inhalación de esporas de un hongo 
llamado Histoplasma capsulatum . La histoplasmosis 
no es contagiosa; no puede ser transmitida de una 
persona o animal enfermo a alguien sano.
¿Cuales son los síntomas de la 
histoplasmosis?
La histoplasmosis afecta principalmente los pul­
mones y sus síntomas son muy variables. La gran 
mayoría de las personas infectadas son asintomáti- 
cas (no tienen efectos aparentes de enfermedad) o 
presentan síntomas tan leves que no requieren aten­
ción médica. Cuando hay síntomas, éstos general­
mente empiezan 3 a 17 días después de la exposi­
ción, con un promedio de 10 días. La histoplasmo­
sis puede aparecer como una enfermedad respirato­
ria leve tipo influenza y tiene una combinación de 
síntomas que incluyen decaimiento (sensación de 
enfermedad), fiebre, dolor en el pecho, tos seca o 
no productiva, dolor de cabeza, pérdida de apetito, 
disnea (dificultad para respirar), dolores muscu­
lares y de articulaciones, calofríos y ronquera. Una 
radiografía de tórax de una persona con histoplas­
mosis pulmonar aguda muestra con frecuencia una 
neumonitis desigual que se calcifica eventual­
mente. La enfermedad pulmonar crónica por histo­
plasmosis se parece a la tuberculosis y puede 
empeorar a través de los meses o años. La forma 
más severa y rara de esta enfermedad es la histo­
plasmosis diseminada, que involucra la invasión 
del hongo a otros órganos fuera de los pulmones.
¿Quién puede contraer histoplasmosis?
Cualquier persona que trabaje o esté presente cerca 
de actividades en donde el material contaminado 
con H. capsulatum  se haga volátil, puede desarrol­
lar histoplasmosis si inhala suficientes esporas. 
Después de una exposición, la severidad de la 
enfermedad es muy variable y probablemente 
dependa del número de esporas inhaladas y de la 
edad y susceptibilidad de la persona a contraer la 
enfermedad. El número de esporas que es nece­
sario inhalar para contraer la enfermedad es 
desconocido. Los niños menores de dos años, las 
personas con sistemas inmunes comprometidos y 
los adultos mayores, en particular aquellos con 
enfermedades subyacentes tales como diabetes y 
enfermedad pulmonar crónica, tienen un mayor 
riesgo de desarrollar histoplasmosis sintomática.
Las personas con deficiencias del sistema inmune 
sufren mayor riesgo de desarrollar histoplasmosis 
severa y diseminada. Incluidos en este grupo de 
alto riesgo se encuentran las personas con SIDA o 
cáncer y las personas que están recibiendo 
quimioterapia, terapia con altas dosis de esteroides 
por tiempo prolongado o terapia con otros medica­
mentos inmunosupresores.
Antes del año 2000, una persona podía saber si 
había sido infectada previamente con H. capsula­
tum  a través de una prueba cutánea con histoplas- 
mina. Sin embargo, la fabricación de histoplasmina 
se descontinuó en 2000, y los reactivos para hacer 
la prueba cutánea seguían sin estar disponibles en el 
2004. Una infección previa puede otorgar inmu­
nidad parcial contra una reinfección. Dado que una 
prueba cutánea positiva no significa que una per­
sona sea completamente inmune a una reinfección, 
deben ser adoptadas medidas apropiadas de protec­
ción contra la exposición. Estas medidas deberán 
ser adoptadas, independientemente de los resulta­
dos de la prueba cutánea, por aquellos trabajadores 
que manipulen materiales que puedan estar contam­
inados con H. capsulatum .
¿Cúal es el tratamiento de la 
histoplasmosis?
Los casos leves de histoplasmosis usualmente se 
resuelven sin tratamiento. Los casos severos 
requieren medicamentos especiales antihongos 
(fungicidas) para controlar la enfermedad. La 
histoplasmosis diseminada es mortal si no se trata, 
pero la muerte también puede ocurrir aún cuando 
se reciba tratamiento médico.
¿Dónde se encuentran las esporas de 
H. capsulatum?
El H. capsulatum  se encuentra en suelos de todo el 
mundo. En los Estados Unidos, el hongo es endémi­
co (más prevalente) y la proporción de gente infecta­
da por H. capsulatum  es mayor en los estados del 
este y el centro, sobre todo a lo largo de los valles de 
los ríos Ohio y Mississippi. El hongo parece crecer 
mejor en suelos con alto contenido de nitrógeno, 
especialmente aquellos enriquecidos con guano de 
murciélago o estiércol de pájaro. La manipulación de 
material contaminado hace que las pequeñas esporas 
de H. capsulatum  se hagan volátiles o se conviertan 
en aerosol. Una vez volátiles, las esporas pueden ser 
fácilmente transportadas por corrientes de viento a 
grandes distancias.
¿Cómo se puede saber si el suelo o el 
guano están contaminadas con esporas de 
H. capsulatum?
Para saber si el suelo o el guano están contaminados 
con esporas de H. capsulatum , se deben tomar mues­
tras para cultivo. Actualmente, el método usado para 
aislar H. capsulatum  es caro y requiere varias semanas 
para completarlo. Si no se toman suficientes muestras, 
pueden ignorarse áreas pequeñas pero muy contami­
nadas. Hasta que exista un método más rápido y 
menos caro, el examen de muestras seguirá siendo 
poco práctico en la mayoría de las situaciones. En con­
secuencia, cuando no se hace un examen extensivo, el 
enfoque más seguro es asumir que el suelo en regiones 
endémicas y cualquier acumulación de guano de mur­
ciélago o estiércol de pájaro, están contaminados con 
H. capsulatum  y, por lo tanto, tomar las medidas nece­
sarias para prevenir la exposición.
¿Qué trabajos y  actividades tienen riesgo de 
exposición a H. capsulatum?
A continuación hay una lista parcial de ocupaciones 
y pasatiempos que tienen riesgo de exposición a 
esporas de H. capsulatum . Estas personas deben 
tomar medidas adecuadas para prevenir la exposi­
ción siempre que se manipule suelo contaminado, 
guano de murciélago o estiércol de pájaro.
> Inspector o pintor de puentes
> Limpiador de chimeneas
> Trabajador de la construcción
> Trabajador de demolición
> Granjero, trabajador agrícola
> Jardinero
> Instalador o agente de servicio de sistemas de 
aire acondicionado y calefacción
> Trabajador de laboratorio microbiológico
> Trabajador de control de plagas
> Restaurador de edificios históricos o abandonados
> Trabajador de techos
> Explorador de cuevas
¿Cómo se puede controlar la exposición a 
H. capsulatum y prevenir la histoplasmosis?
La mejor forma de prevenir la exposición a las espo­
ras de H. capsulatum  es evitar aquellas situaciones 
donde materiales contaminados puedan hacerse
volátiles y las esporas ser posteriormente inhaladas. 
Esto es importante sobre todo para aquellas personas 
con depresión del sistema inmune.
Los métodos de supresión de polvo, tal como 
humedecer cuidadosamente con un aspersor de 
agua, pueden ser útiles para reducir la cantidad de 
material que se volatiliza durante una actividad. Para 
algunas actividades, tales como remover una acumu­
lación de guano de murciélago o estiércol de pájaro 
de un lugar cerrado, cómo un ático, se debe usar un 
respirador aprobado por NIOSH. Otros artículos de 
protección personal pueden ser necesarios para dis­
minuir el riesgo de exposición a H. capsulatum . Sin 
embargo, sólo las personas capacitadas en la selec­
ción y el uso adecuados del equipo de protección 
personal deben llevar a cabo actividades donde este 
equipo sea requerido.
Ocasionalmente se han usado desinfectantes para 
tratar el suelo y la acumulación de guano de mur­
ciélago, cuando la remoción no es práctica, o como 
una precaución antes de iniciar el proceso de remo­
ción. No existe producto o agente químico registrado 
por la EPA (Agencia de Protección Ambiental) que 
sea efectivo contra H. capsulatum . El fabricante de 
algún producto que afirme que desinfecta el suelo 
contaminado con H. capsulatum  tendrá que cumplir 
con los requisitos regulatorios de la EPA y completar 
el proceso de registro.
¿Dónde se puede obtener m ás inform ación sobre 
la histoplasm osis?
Esta hoja informativa sobre la histoplasmosis fue 
preparada por el Instituto Nacional de Salud y 
Seguridad Ocupacional (NIOSH) y el Centro 
Nacional de Enfermedades Infecciosas (NCID), 
ambos de los Centros de Control y Prevención de 
Enfermedades. Para respuestas a otras preguntas 
sobre histoplasmosis, por favor contacte a su médico, 
a su departamento de salud local, o al NCID en 
Atlanta, Georgia. La dirección de Internet del NCID 
es http://www.cdc.gov/ncidod/. Para otras consultas 
sobre la salud de los trabajadores y medidas de pre­
caución a usar durante la manipulación de suelo, 
guano de murciélago o estiércol de pájaro potencial­
mente contaminados con esporas de H. capsulatum , 
llame a NIOSH en Cincinnati, Ohio, al teléfono 
(800) 356-4674.
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